The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| XSPA | -46.16% | -97.51% | -52.23% | -100% |
| S&P | +14.5% | +93.32% | +14.09% | +392% |
XWELL, Inc. provides global travel health and wellness services. It operates through the following segments: XpresSpa, XpresTest, Treat, and Corporate and Other. The XpresSpa segment offers travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment deals with diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public. The Treat segment consists of access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place. The company was founded by Jonathan Medved and David Goldfarb on January 9, 2006 and is headquartered in New York, NY.
Shares of the airport spa operator gained as it opened two new COVID-19 testing facilities.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $7.69M | -17.2% |
| Gross Profit | $1.59M | -44.3% |
| Gross Margin | 20.65% | -10.1% |
| Market Cap | $4.85M | -35.6% |
| Market Cap / Employee | $0.02M | 0.0% |
| Employees | 312 | -7.4% |
| Net Income | -$2.05M | -14.6% |
| EBITDA | -$2.26M | -70.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $5.26M | -2.9% |
| Accounts Receivable | $1.47M | -38.3% |
| Inventory | 0.6 | -35.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $8.22M | -4.6% |
| Short Term Debt | $2.18M | -12.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -65.83% | -20.6% |
| Return On Invested Capital | -102.81% | 35.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$3.28M | -311.4% |
| Operating Free Cash Flow | -$2.39M | -438.6% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.82 | 1.26 | 0.85 | -0.84 | -217.60% |
| Price to Sales | 0.25 | 0.23 | 0.17 | 0.16 | -28.70% |
| Price to Tangible Book Value | 1.16 | 2.08 | 1.41 | -0.60 | -162.46% |
| Enterprise Value to EBITDA | -3.08 | -4.76 | -4.97 | -7.14 | 9.28% |
| Return on Equity | -123.3% | -276.0% | -797.7% | -1069.0% | 868.29% |
| Total Debt | $11.62M | $10.77M | $10.59M | $10.40M | -6.29% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
